ADAM PAYNE: Open Payments
NPI 1417279035 · FISHKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 46 payments from 12 companies in 2025. Trend: 2023 $1,421 · 2024 $1,171 · 2025 $1,024
Food & beverage: $924Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $322 |
| ABBVIE INC. | 15 | $221 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| LEO Pharma Inc. | 3 | $75 |
| Lilly USA, LLC | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Organon LLC | 3 | $43 |
| Galderma Laboratories, L.P. | 2 | $38 |
| UCB, Inc. | 1 | $35 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, TALTZ, ADBRY, Sotyktu, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
